Management of asymptomatic patients with severe mitral valve regurgitation is controversial—conservative surveillance and early mitral valve repair have ... the optimal care of this population ...

Yet the long-term growth potential of healthcare can’t be ignored — the sector accounts for 10.2% of global GDP and with the global GDP projected to reach $137 trillion by 2030, there will be some $14 ...

Valvular heart disease can't be cured, but it can be treated with valve replacement or repair. These procedures ... 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart ...

Heart valve surgery is a procedure to treat heart valve disease, which happens when at least one of the four heart valves is ...

This review aims to outline the current evidence base and guidance for care ... valve surgery or intervention but this may be considered on a case-by-case basis. Women of childbearing age should be ...

We recently compiled a list of the 12 Cheap Healthcare Stocks to Buy Heading into 2025. In this article, we are going to take ...

These Jefferies Franchise Picks for 2025 look like outstanding ideas for growth and income investors, as they offer reliable ...

Edwards Lifesciences Co. (NYSE:EW – Get Free Report) passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $72.91 and traded as high as $75.35.

JA Moody is a premier maritime supplier of fluid control products and technical services to the U.S. Navy and select commercial marine markets. The Company's product portfolio, including MILSPEC ...

Dealmaking slowed in December compared to the previous two months, though year-to-date activity remained strong to outpace ...

Based on the results from the MATTERHORN (A Multicenter, Randomized, Controlled Study to Assess Mitral Valve Reconstruction for Advanced Insufficiency of Functional or Ischemic Origin), transcatheter ...